What are the major opportunities in the Next Generation In Vitro Diagnostics IVD market? What are the strategies for the Next Generation In Vitro Diagnostics IVD market?

For detailed insights on the major opportunities and strategies in the Next Generation In Vitro Diagnostics IVD market, Read More

How does the Next Generation In Vitro Diagnostics IVD market relate to the overall economy and other similar markets?

For detailed insights on Next Generation In Vitro Diagnostics IVD's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Next Generation In Vitro Diagnostics IVD market growth? SWOT analysis of the Next Generation In Vitro Diagnostics IVD market.

For detailed insights on the key dynamics influencing the Next Generation In Vitro Diagnostics IVD market growth and SWOT analysis of the Next Generation In Vitro Diagnostics IVD industry, Read More

Next-Generation In Vitro Diagnostics (IVD) Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Next-Generation In Vitro Diagnostics (IVD) Market Report 2026

Name: Next-Generation In Vitro Diagnostics (IVD) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Consumables, Instruments, Software), By Diagnostic Modality (Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics), By Application (Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology , Other Applications), By End-User (Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Next-Generation In Vitro Diagnostics (IVD) Market Overview

• Next-Generation In Vitro Diagnostics (IVD) market size has reached to $117.97 billion in 2025

• Expected to grow to $188.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Rising Demand For Personalized Medicine Fuelling The Growth Of The Next-Generation In Vitro Diagnostics (IVD) Market Due To Increasing Availability Of Genomic Data

• Market Trend: Strategic Partnerships Fueling Innovation In Diagnostic Technologies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next-Generation In Vitro Diagnostics (IVD) Market?

Next-generation in vitro diagnostics (IVD) refers to advanced diagnostic technologies and tools that analyze biological samples, such as blood, saliva, or tissue, outside the body to detect diseases, conditions, or infections with greater accuracy, speed, and personalization. These technologies often integrate innovations such as genomics, AI, digital health platforms, and high-throughput sequencing. The primary purpose of next-generation IVD is to enable earlier, more precise, and patient-specific diagnosis and monitoring of diseases, including cancer, infectious diseases, and genetic disorders.

The main product type of next-generation in vitro diagnostics (IVD) includes consumables, instruments, software, and more. Core laboratory diagnostics refers to centralized testing services that analyze a wide range of biological samples using automated, high-throughput instruments and assays. It includes various types such as core laboratory diagnostics, point-of-care testing, molecular diagnostics. It is used for various applications which include oncology or cancer, infectious diseases, diabetes, cardiology, and other diagnostic areas, for varied end users such as hospitals and clinics, diagnostic laboratories, academic and research institutions, and other healthcare providers.

Next-Generation In Vitro Diagnostics (IVD) market report bar graph

What Is The Next-Generation In Vitro Diagnostics (IVD) Market Size and Share 2026?

The next-generation in vitro diagnostics (ivd) market size has grown rapidly in recent years. It will grow from $117.97 billion in 2025 to $129.89 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, growing burden of chronic diseases, increased adoption of molecular diagnostics, expansion of clinical laboratory infrastructure, government funding for diagnostic programs.

What Is The Next-Generation In Vitro Diagnostics (IVD) Market Growth Forecast?

The next-generation in vitro diagnostics (ivd) market size is expected to see strong growth in the next few years. It will grow to $188.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine, expansion of genomic testing applications, growing adoption of point-of-care diagnostics, rising healthcare digitization, increasing investments in diagnostic R&D. Major trends in the forecast period include shift toward personalized and companion diagnostics, rapid adoption of point-of-care and decentralized testing, integration of multiplex and high-throughput assays, rising demand for early disease detection and screening, growth of non-invasive and liquid biopsy diagnostics.

Book your 30 minutes free consultation with our research experts

Global Next-Generation In Vitro Diagnostics (IVD) Market Segmentation

1) By Product Type: Consumables, Instruments, Software

2) By Diagnostic Modality: Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics

3) By Application: Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology , Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users

Subsegments:

1) By Consumables: Assay Kits And Reagents, Specimen Bags and Tubes, Seals and Caps

2) By Instruments: Automated Sample Preparation Systems, High-Throughput Molecular Diagnostic Analyzers, Next-Generation Sequencing Platforms, Integrated Diagnostic Workstations And Analysis Platforms, Digital PCR Systems And Advanced Real-Time PCR Instruments

3) By Software: Laboratory Information Management Systems, Specimen Tracking Software Modules, Cloud-Based Tracking Software

What Is The Driver Of The Next-Generation In Vitro Diagnostics (IVD) Market?

The increasing demand for personalized medicine is expected to propel the growth of the next-generation in vitro diagnostics (IVD) market going forward. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual’s genetic profile, environment, and lifestyle. Personalized medicine is rising due to the growing availability of genomic data, which allows healthcare providers to design targeted treatments based on a person’s unique genetic makeup, leading to more effective care. Next-generation in vitro diagnostics (IVD) supports personalized medicine by providing precise molecular and genetic insights that enable tailored treatment and prevention strategies for individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the next-generation in vitro diagnostics (IVD) industry.

Key Players In The Global Next-Generation In Vitro Diagnostics (IVD) Market

Major companies operating in the next-generation in vitro diagnostics (ivd) market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc

Global Next-Generation In Vitro Diagnostics (IVD) Market Trends and Insights

Major companies operating in the next-generation in vitro diagnostics (IVD) market are adopting A strategic partnerships approach in next-generation in vitro diagnostics involves collaborating with technology providers, research institutions, and healthcare organizations to accelerate innovation, enhance diagnostic accuracy, and expand access to advanced testing solutions for individuals, businesses, and governments. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2024, Yourgene Health, a UK-based biotechnology company, partnered with Genetix, a Colombia-based human genetic diagnosis company, to launch Colombia’s first local non-invasive prenatal testing (NIPT) service. This initiative represents a significant advancement in prenatal care in the region, offering expectant parents faster, more reliable, and cost-effective access to advanced genetic screening. The service utilizes Yourgene Health’s IONA Nx NIPT Workflow, a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow is highly flexible and scalable, suitable for varying sample volumes, and enables Genetix to offer a quality-assured prenatal screening service within Colombia.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Next-Generation In Vitro Diagnostics (IVD) Market?

In February 2023, SD Biosensor Inc., a South Korea-based company specializing in in-vitro diagnostics, and SJL Partners LLC, a South Korea-based investment company, acquired Meridian Bioscience Inc. for $1.53 billion. With the acquisition, SD Biosensor aims to leverage Meridian's expertise in diagnostic products and raw materials used in immunological and molecular tests for various applications. Meridian Bioscience Inc. is a US-based diagnostic company that provides in vitro diagnostic enzymes.

Regional Outlook

North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Next-Generation In Vitro Diagnostics (IVD) Market?

The next-generation in vitro diagnostics (IVD) market consists of revenues earned by entities providing services such as genomic testing services, molecular diagnostics services, and companion diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation in vitro diagnostics (IVD) market also includes sales of molecular diagnostics kits, proteomics-based diagnostic kits, and NGS sample preparation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next-Generation In Vitro Diagnostics (IVD) Market Report 2026?

The next-generation in vitro diagnostics (ivd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation in vitro diagnostics (ivd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Next-Generation In Vitro Diagnostics (IVD) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$129.89 billion
Revenue Forecast In 2035	$188.69 billion
Growth Rate	CAGR of 10.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Diagnostic Modality, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Next-Generation In Vitro Diagnostics (IVD) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Next-Generation In Vitro Diagnostics (IVD) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Next-Generation In Vitro Diagnostics (IVD) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Next-Generation In Vitro Diagnostics (IVD) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Shift Toward Personalized And Companion Diagnostics

4.2.2 Rapid Adoption Of Point-Of-Care And Decentralized Testing

4.2.3 Integration Of Multiplex And High-Throughput Assays

4.2.4 Rising Demand For Early Disease Detection And Screening

4.2.5 Growth Of Non-Invasive And Liquid Biopsy Diagnostics

5. Next-Generation In Vitro Diagnostics (IVD) Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Academic And Research Institutions

5.4 Biotechnology And Pharmaceutical Companies

5.5 Contract Research Organizations

6. Next-Generation In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation In Vitro Diagnostics (IVD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next-Generation In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Next-Generation In Vitro Diagnostics (IVD) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation In Vitro Diagnostics (IVD) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation In Vitro Diagnostics (IVD) Market Segmentation

9.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consumables, Instruments, Software

9.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics

9.3. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology, Other Applications

9.4. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users

9.5. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Assay Kits And Reagents, Specimen Bags and Tubes, Seals and Caps

9.6. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Automated Sample Preparation Systems, High-Throughput Molecular Diagnostic Analyzers, Next-Generation Sequencing Platforms, Integrated Diagnostic Workstations And Analysis Platforms, Digital PCR Systems And Advanced Real-Time PCR Instruments

9.7. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratory Information Management Systems, Specimen Tracking Software Modules, Cloud-Based Tracking Software

10. Next-Generation In Vitro Diagnostics (IVD) Market Regional And Country Analysis

10.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market

11.1. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation In Vitro Diagnostics (IVD) Market

12.1. China Next-Generation In Vitro Diagnostics (IVD) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation In Vitro Diagnostics (IVD) Market

13.1. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation In Vitro Diagnostics (IVD) Market

14.1. Japan Next-Generation In Vitro Diagnostics (IVD) Market Overview

14.2. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation In Vitro Diagnostics (IVD) Market

15.1. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market

16.1. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation In Vitro Diagnostics (IVD) Market

17.1. South Korea Next-Generation In Vitro Diagnostics (IVD) Market Overview

17.2. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market

18.1. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market Overview

18.2. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market

19.1. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market Overview

19.2. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market

20.1. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview

20.2. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation In Vitro Diagnostics (IVD) Market

21.1. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation In Vitro Diagnostics (IVD) Market

22.1. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation In Vitro Diagnostics (IVD) Market

23.1. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation In Vitro Diagnostics (IVD) Market

24.1. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation In Vitro Diagnostics (IVD) Market

25.1. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market

26.1. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview

26.2. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation In Vitro Diagnostics (IVD) Market

27.1. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation In Vitro Diagnostics (IVD) Market

28.1. North America Next-Generation In Vitro Diagnostics (IVD) Market Overview

28.2. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation In Vitro Diagnostics (IVD) Market

29.1. USA Next-Generation In Vitro Diagnostics (IVD) Market Overview

29.2. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation In Vitro Diagnostics (IVD) Market

30.1. Canada Next-Generation In Vitro Diagnostics (IVD) Market Overview

30.2. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation In Vitro Diagnostics (IVD) Market

31.1. South America Next-Generation In Vitro Diagnostics (IVD) Market Overview

31.2. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation In Vitro Diagnostics (IVD) Market

32.1. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation In Vitro Diagnostics (IVD) Market

33.1. Middle East Next-Generation In Vitro Diagnostics (IVD) Market Overview

33.2. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation In Vitro Diagnostics (IVD) Market

34.1. Africa Next-Generation In Vitro Diagnostics (IVD) Market Overview

34.2. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation In Vitro Diagnostics (IVD) Market Regulatory and Investment Landscape

36. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

36.1. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Next-Generation In Vitro Diagnostics (IVD) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Next-Generation In Vitro Diagnostics (IVD) Market Company Profiles

36.3.1. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc

38. Global Next-Generation In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation In Vitro Diagnostics (IVD) Market

40. Next-Generation In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

40.1 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Countries Offering Most New Opportunities

40.2 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Segments Offering Most New Opportunities

40.3 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Next-Generation In Vitro Diagnostics (IVD) Market, Overview Of Key Products - Product Examples

Table 2: Global Next-Generation In Vitro Diagnostics (IVD) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Next-Generation In Vitro Diagnostics (IVD) Market, Supply Chain Analysis

Table 4: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Raw Material Providers

Table 5: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Resource Providers

Table 6: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Manufacturers (Suppliers)

Table 7: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Distributors And Channel Partners

Table 8: Global Next-Generation In Vitro Diagnostics (IVD) Market, Key Technologies & Future Trends

Table 9: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Trends

Table 10: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major End Users

Table 11: Global Next-Generation In Vitro Diagnostics (IVD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Next-Generation In Vitro Diagnostics (IVD) Market - TAM, US$ Billion, 2025

Table 15: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Next-Generation In Vitro Diagnostics (IVD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Next-Generation In Vitro Diagnostics (IVD) Market - Company Scoring Matrix

Table 98: F Hoffmann La Roche AG Financial Performance

Table 99: Thermo Fisher Scientific Inc Financial Performance

Table 100: Abbott Laboratories Financial Performance

Table 101: Becton Dickinson And Company Financial Performance

Table 102: Agilent Technologies Inc Financial Performance

Table 103: Global Next-Generation In Vitro Diagnostics (IVD) Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Next-Generation In Vitro Diagnostics (IVD) Market, Competitive Dashboard

Table 105: Global Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 107: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Diagnostic Modality, 2025 – 2030

Table 108: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Next-Generation In Vitro Diagnostics (IVD) Market, Overview Of Key Products - Product Examples

Figure 2: Global Next-Generation In Vitro Diagnostics (IVD) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Next-Generation In Vitro Diagnostics (IVD) Market, Supply Chain Analysis

Figure 4: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Raw Material Providers

Figure 5: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Resource Providers

Figure 6: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Manufacturers (Suppliers)

Figure 7: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Distributors And Channel Partners

Figure 8: Global Next-Generation In Vitro Diagnostics (IVD) Market, Key Technologies & Future Trends

Figure 9: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major Trends

Figure 10: Global Next-Generation In Vitro Diagnostics (IVD) Market, Major End Users

Figure 11: Global Next-Generation In Vitro Diagnostics (IVD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Next-Generation In Vitro Diagnostics (IVD) Market - TAM, US$ Billion, 2025

Figure 15: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Next-Generation In Vitro Diagnostics (IVD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Next-Generation In Vitro Diagnostics (IVD) Market - Company Scoring Matrix

Figure 98: F Hoffmann La Roche AG Financial Performance

Figure 99: Thermo Fisher Scientific Inc Financial Performance

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Becton Dickinson And Company Financial Performance

Figure 102: Agilent Technologies Inc Financial Performance

Figure 103: Global Next-Generation In Vitro Diagnostics (IVD) Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Next-Generation In Vitro Diagnostics (IVD) Market, Competitive Dashboard

Figure 105: Global Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 107: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Diagnostic Modality, 2025 – 2030

Figure 108: Global, Next-Generation In Vitro Diagnostics (IVD) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

In Vitro Diagnostics Market Report 2026 - Global Outlook – By Diagnostic (Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equi...

In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report 2026 - Global Outlook – By Product Type (Instruments, Reagents And Consumables, Software And Services), By Technology (Immunoassays, Molecular Diagnosti...

Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report 2026 - Global Outlook – By Component (Hardware, Software), By Type Of Test (Blood Based Tests, Tissue Based Tests), By Application (Cardiovascular Diseas...

In Vitro Diagnostics Enzymes Market Report 2026 - Global Outlook – By Enzyme Type (Proteases, Polymerase And Transcriptase, Ribonuclease, Other Enzyme Types), By Disease Type (Infectious Disease, Diabetes, Oncology, Card...

Biologics Testing Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Instruments, Other Products), By Test Type (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Pro...

In-Vitro Toxicology Testing Market Report 2026 - Global Outlook – By Product And Service (Consumables, Assays, Equipment, Software, Services), By Technology (Cell Culture Technologies, High-throughput Technologies, Toxic...

Cell Viability Assays Market Report 2026 - Global Outlook – By Product (Consumables, Instruments), By Application (Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications,...

Frequently Asked Questions

How big is the Next-Generation In Vitro Diagnostics (IVD) Market?

The Next-Generation In Vitro Diagnostics (IVD) market was valued at $117.97 billion in 2025, increased to $129.89 billion in 2026, and is projected to reach $188.69 billion by 2030.

What is the Next-Generation In Vitro Diagnostics (IVD) market growth?

The global Next-Generation In Vitro Diagnostics (IVD) market is expected to grow at a CAGR of 9.8% from 2026 to 2035 to reach $188.69 billion by 2035.

Who are the key players in Next-Generation In Vitro Diagnostics (IVD) market?

Some Key Players in the Next-Generation In Vitro Diagnostics (IVD) market Include, F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc .

What is the anticipated growth trend for the Next-Generation In Vitro Diagnostics (IVD) market?

Major trend in this market includes: Strategic Partnerships Fueling Innovation In Diagnostic Technologies. For further insights on this market. request a sample here

Which region has the most growth potential in the Next-Generation In Vitro Diagnostics (IVD) market?

North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.